DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2023
    • Call for Papers
    • Sponsor and Exhibit
    • New Researcher Network
    • Conference Logistics
    • Media Partners
  • Archive
    • Conference Papers Archive
    • DDL2022
      • APS Workshop
      • Conference Papers
      • DDL2022 Programme
      • DDL2022 Speakers
      • DDL2022 Sponsors
      • DDL2022 Photo Album
    • DDL2021
      • Conference Papers
      • DDL2021 Programme
      • DDL2021 Speakers
      • DDL2021 Sponsors
    • DDL2020
      • Conference Papers
      • Speakers and Lecture Recordings
      • Sponsors
    • DDL2019
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2019 Photo Album
    • DDL2018
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2018 Photo Album
    • DDL2017
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2017 Photo Album
    • DDL2016
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2015
      • Conference Papers
    • Previous Years
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • Scientific Advisors
  • Associated Events
    • EPSRC CDT in Aerosol Science Annual Conference 2023
    • ERS International Congress 2023
    • ISAM Congress 2023
    • RDD Europe 2023
  • Contact
  • The Aerosol Society logo
Matt Bonam :

Matt Bonam

Global Head, Biopharma R&D Digital Patient Health, AstraZeneca

During his 19 years at AstraZeneca, Matt has moved through a number of technical line management and project management roles within the business and is currently the Global Head of R&D Digital Patient Health. Matt’s academic background is as a chemist, obtaining his degree at University of Liverpool before moving into the Pharma industry initially as an analytical scientist characterising product performance before moving into project management and project leadership before founding a digital health innovation group within AZ.
The R&D Digital Patient Health group’s mission is to develop digital health solutions which deliver improved clinical outcomes for patients. The group develops tools for use in all phases of the pharmaceutical product lifecycle, delivering its products globally across all therapy areas in which AZ has focus. Having started his career characterising the impact of medication use and misuse on drug delivery Matt is delighted to now be able to deliver tools to patients which robustly improve medication use, collect data directly from patients to support self-management, and improve clinical outcomes.

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2023 Drug Delivery to the Lungs Website design: definingdesign.co.uk